Clinical Trial Update: A Phase 1/3 Clinical Trial to Evaluate the Safety and Efficacy of HUTOX Compared to Botox® in Subjects With Moderate to Severe Crow's Feet Lines [Phase 3]

View source ↗

Summary

Phase 1/3 trial evaluating safety and efficacy of HUTOX vs Botox in moderate to severe crow's feet lines, currently status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crow Feet Lines

Drugs mentioned

• Botox (OnabotulinumtoxinA)
• Hutox (botulinum toxin type A)

Snippet

Sponsor: Huons Co., Ltd. | Conditions: Crow's Feet Lines | Phase 3 | Status: UNKNOWN